NASDAQ:AZN

AstraZeneca SEC Filings & 10K Form

$59.48
+0.74 (+1.26 %)
(As of 09/23/2021 04:00 PM ET)
Add
Compare
Today's Range
$59.24
$59.76
50-Day Range
$55.56
$59.59
52-Week Range
$46.48
$60.93
Volume5.32 million shs
Average Volume9.89 million shs
Market Capitalization$184.28 billion
P/E Ratio41.31
Dividend Yield2.33%
Beta0.53

AstraZeneca (NASDAQ:AZN) SEC Filings

DateFilerForm TypeView
09/21/2021
5:54 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2021
5:38 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2021
10:16 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2021
6:43 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2021
5:18 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2021
5:30 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2021
5:22 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2021
5:31 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2021
5:20 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2021
9:44 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/11/2021
9:49 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2021
6:41 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2021
6:31 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2021
9:41 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2021
5:23 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2021
6:39 AM
AstraZeneca (Filer)
Form 6-K/A
07/26/2021
5:15 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2021
7:15 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/21/2021
11:09 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/21/2021
10:54 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/21/2021
8:52 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/19/2021
5:23 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2021
5:13 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/14/2021
11:12 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
07/14/2021
5:30 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2021
5:05 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2021
1:11 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
07/06/2021
10:13 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
07/06/2021
5:50 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2021
10:20 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2021
3:23 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
06/29/2021
9:56 AM
AstraZeneca (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/28/2021
6:05 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2021
5:50 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2021
6:17 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2021
5:45 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/22/2021
6:21 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/15/2021
5:05 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/07/2021
5:19 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2021
3:44 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
06/04/2021
1:59 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
06/04/2021
5:27 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2021
5:22 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2021
5:24 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2021
11:28 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2021
10:54 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2021
3:15 PM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2021
5:06 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/27/2021
4:28 PM
AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
Form 424B2
05/27/2021
1:05 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
05/27/2021
5:40 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2021
6:16 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2021
5:06 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2021
5:02 AM
AstraZeneca (Subject)
Form FWP
05/26/2021
5:01 AM
AstraZeneca (Subject)
Form FWP
05/25/2021
5:46 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2021
3:22 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
05/24/2021
7:56 AM
AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
Form 424B2
05/24/2021
7:37 AM
AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
Form F-3ASR
05/24/2021
7:18 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2021
5:23 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/18/2021
10:41 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2021
9:20 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2021
9:00 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2021
2:04 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
05/07/2021
5:28 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2021
2:03 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
05/05/2021
7:20 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
05/04/2021
12:43 PM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/04/2021
7:19 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2021
11:21 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
04/30/2021
6:21 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2021
6:12 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2021
6:05 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2021
5:59 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2021
11:45 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
04/16/2021
7:50 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
04/16/2021
7:15 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/14/2021
5:23 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2021
11:15 PM
AstraZeneca (Filer)
Form EFFECT
04/12/2021
11:08 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
04/12/2021
11:07 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2021
11:07 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2021
11:02 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
04/12/2021
6:14 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2021
4:04 PM
AstraZeneca (Filer)
Form F-4/A
04/01/2021
12:46 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
04/01/2021
12:46 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
04/01/2021
12:45 PM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
04/01/2021
10:17 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2021
7:19 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2021
6:21 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2021
10:23 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2021
7:14 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/16/2021
7:52 AM
AstraZeneca (Reporting)
AstraZeneca UK LTD (Reporting)
Viela Bio, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
6:19 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/16/2021
6:11 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2021
8:30 AM
ALEXION PHARMACEUTICALS, INC. (Subject)
AstraZeneca (Filed by)
Form 425
03/09/2021
10:15 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2021
9:54 AM
AstraZeneca (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 9/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.